Terms: = Prostate cancer AND ERCC3, RAD25, 2071, ENSG00000163161, GTF2H, TFIIH, BTF2, P19447, XPB
12 results:
1. [Bioinformatics-based analysis of the effect of general Transcription Factor IIH on prognosis of prostate cancer].
Li JC; Zhu XJ; Ye JH; Tan ZH; Cai SH; Deng YL; Chen J; Tian WC; Luo DH; Zhong WD
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1410-1417. PubMed ID: 38644292
[No Abstract] [Full Text] [Related]
2. DNA repair gene polymorphisms, tumor control, and treatment toxicity in prostate cancer patients treated with permanent implant prostate brachytherapy.
Carignan D; Lessard T; Villeneuve L; Desjardins S; Magnan S; Després P; Martin AG; Foster W; Guillemette C; Lévesque É; Vigneault E
Prostate; 2020 May; 80(8):632-639. PubMed ID: 32201973
[TBL] [Abstract] [Full Text] [Related]
3. Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant prostate cancer Cells.
Han Y; Huang W; Liu J; Liu D; Cui Y; Huang R; Yan J; Lei M
Theranostics; 2017; 7(7):1914-1927. PubMed ID: 28638477
[TBL] [Abstract] [Full Text] [Related]
4. Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation.
He QL; Minn I; Wang Q; Xu P; Head SA; Datan E; Yu B; Pomper MG; Liu JO
Angew Chem Int Ed Engl; 2016 Sep; 55(39):12035-9. PubMed ID: 27574181
[TBL] [Abstract] [Full Text] [Related]
5. prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer.
Thomsen FB; Christensen IJ; Brasso K; Røder MA; Iversen P
BJU Int; 2014 May; 113(5b):E98-105. PubMed ID: 24053601
[TBL] [Abstract] [Full Text] [Related]
6. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
Ma Q; Qi C; Tie C; Guo Z
Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729
[TBL] [Abstract] [Full Text] [Related]
7. Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells.
Koeppel F; Poindessous V; Lazar V; Raymond E; Sarasin A; Larsen AK
Clin Cancer Res; 2004 Aug; 10(16):5604-13. PubMed ID: 15328203
[TBL] [Abstract] [Full Text] [Related]
8. Molecular communication between androgen receptor and general transcription machinery.
Lee DK; Chang C
J Steroid Biochem Mol Biol; 2003 Jan; 84(1):41-9. PubMed ID: 12648523
[TBL] [Abstract] [Full Text] [Related]
9. Tumor-associated antigen human chorionic gonadotropin beta contains numerous antigenic determinants recognized by in vitro-induced CD8+ and CD4+ T lymphocytes.
Dangles V; Halberstam I; Scardino A; Choppin J; Wertheimer M; Richon S; Quelvennec E; Moirand R; Guillet JG; Kosmatopoulos K; Bellet D; Zeliszewski D
Cancer Immunol Immunother; 2002 Feb; 50(12):673-81. PubMed ID: 11862419
[TBL] [Abstract] [Full Text] [Related]
10. Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation.
Lee DK; Duan HO; Chang C
J Biol Chem; 2001 Mar; 276(13):9978-84. PubMed ID: 11266437
[TBL] [Abstract] [Full Text] [Related]
11. From androgen receptor to the general transcription factor tfiih. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator.
Lee DK; Duan HO; Chang C
J Biol Chem; 2000 Mar; 275(13):9308-13. PubMed ID: 10734072
[TBL] [Abstract] [Full Text] [Related]
12. Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction.
Cheng L; Guan Y; Li L; Legerski RJ; Einspahr J; Bangert J; Alberts DS; Wei Q
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):801-7. PubMed ID: 10498399
[TBL] [Abstract] [Full Text] [Related]
